Outcomes after switching from one anti-tumor necrosis factor alpha agent to a second anti-tumor necrosis factor alpha agent in patients with rheumatoid arthritis: results from a large UK national cohort study.
Arthritis Rheum. 2007 Jan;56(1):13-20. doi: 10.1002/art.22331.
Arthritis Rheum. 2007.
PMID: 17195186
Free article.